Osteoblast response to fluid induced shear depends on substrate microarchitecture and varies with time
Source abstract
Abstract
Abstract Osteoblasts are exposed to fluid shear in vivo but the effects are not well understood, particularly how substrate properties or length of exposure modify the response. Short exposure (1 h) to shear reduces the stimulatory effect of micron‐scale surface structure on osteoblast differentiation, but the effects of longer term exposures are not known. To test the hypothesis that substrate‐dependent responses of osteoblasts to shear depend on the length of exposure to fluid flow, MG63 osteoblasts were grown on tissue culture glass, which has an average roughness (Ra) < 0.2 μm; machined Ti disks (PT, Ra < 0.6 μm); Ti disks with a complex microarchitecture [sand blasted acid etched (SLA), Ra = 4–5 μm); and Ti plasma‐sprayed surfaces [Ti via plasma spray (TPS), Ra = 7 μm]. Confluent cultures were exposed to pulsatile flow at shear forces of 0, 1, and 14 dynes/cm2 for 0, 6, 12, and 24 h. Shear reduced cell number on all surfaces, with greatest effects on TPS. Shear had no effect on alkaline phosphatase on smooth surfaces but increased enzyme activity on SLA and TPS in a time‐dependent manner. Its effects on osteocalcin, TGF‐β1, and PGE2 in the conditioned media were greatest on these surfaces as well. Responses to fluid‐induced shear were blocked by the general Cox inhibitor indomethacin and the Cox‐2 inhibitor meloxicam, indicating that response to shear is mediated by prostaglandin produced via a Cox‐2 dependent mechanism. These results show that the effects of fluid induced shear change with time and are substrate dependent, suggesting that substrate microarchitecture regulates the osteoblast phenotype and effects of shear are determined by the maturation state of the responding population. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2007
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Bone health and osteoporosis research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. 10.1002/jcb.1028410.1002/jcb.10284 ↗
2. 10.1016/S8756-3282(02)00707-X10.1016/S8756-3282(02)00707-X ↗
3. Osteocytes: A proposed multifunctional bone cell
4. 10.1091/mbc.e04-10-091210.1091/mbc.e04-10-0912 ↗
5. 10.1210/en.2002-22113610.1210/en.2002-221136 ↗
6. 10.1359/jbmr.2001.16.2.24910.1359/jbmr.2001.16.2.249 ↗
7. 10.1114/1.159066310.1114/1.1590663 ↗
8. 10.1007/s00223-004-0238-210.1007/s00223-004-0238-2 ↗
9. 10.1359/jbmr.2000.15.11.216910.1359/jbmr.2000.15.11.2169 ↗
10. 10.1016/S8756-3282(00)00323-910.1016/S8756-3282(00)00323-9 ↗
11. 10.1074/jbc.M30299320010.1074/jbc.M302993200 ↗
12. 10.1091/mbc.e04-10-091210.1091/mbc.e04-10-0912 ↗
13. 10.1111/j.1600-0501.2004.01054.x10.1111/j.1600-0501.2004.01054.x ↗
14. 10.1002/jcb.24056031010.1002/jcb.240560310 ↗
15. 10.1002/jbm.82029031410.1002/jbm.820290314 ↗
16. 10.1002/jbm.1029010.1002/jbm.10290 ↗
17. 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L ↗
18. Osteoblast responses to BMP‐2‐treated titanium in vitro
19. 10.1002/jbm.a.3032710.1002/jbm.a.30327 ↗
20. 10.1002/jbm.1003710.1002/jbm.10037 ↗
21. 10.1034/j.1600-0501.2001.012001052.x10.1034/j.1600-0501.2001.012001052.x ↗
22. 10.3233/BIR-1994-3120410.3233/BIR-1994-31204 ↗
23. 10.1002/jbm.82025070810.1002/jbm.820250708 ↗
24. Wilke HJ · 1990 · 309
25. 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q ↗
26. 10.1034/j.1600-0501.1996.070306.x10.1034/j.1600-0501.1996.070306.x ↗
27. 10.1016/S0142-9612(00)00241-610.1016/S0142-9612(00)00241-6 ↗
28. Substrate surface roughness affects growth factor and prostaglandin production by MG63 cells
29. 10.1002/jbm.a.3032010.1002/jbm.a.30320 ↗
30. 10.1002/jbm.a.3013410.1002/jbm.a.30134 ↗
31. 10.1002/(SICI)1097-4636(199911)47:2<139::AID-JBM4>3.0.CO;2-210.1002/(SICI)1097-4636(199911)47:2<139::AID-JBM4>3.0.CO;2-2 ↗
32. 10.1002/jcp.104123031610.1002/jcp.1041230316 ↗
33. Cartilage collagenase is increased in osteoarthritis after anterior cruciate ligament transection (ACLT) regardless of severity of synovitis
34. Effects of combining transforming growth factor β and 1,25‐dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG‐63)10.1016/S0021-9258(19)50371-4 ↗
35. Localization of 1,25‐(OH)2D3 responsive alkaline phosphatase in osteoblast‐like cells (ROS 17/2.8, MG 63, and MC 3T3) and growth cartilage cells in culture10.1016/S0021-9258(18)80148-X ↗
36. 10.1016/8756-3282(92)90361-Y10.1016/8756-3282(92)90361-Y ↗
37. 10.1016/0306-3623(95)02035-710.1016/0306-3623(95)02035-7 ↗
38. 10.1002/jbmr.565001060210.1002/jbmr.5650010602 ↗
39. Bretaudiere JP · 1984 · 75
40. 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O ↗
41. 10.1620/tjem.191.12710.1620/tjem.191.127 ↗
42. 10.1055/s-2004-82101410.1055/s-2004-821014 ↗
43. 10.1074/jbc.M30299320010.1074/jbc.M302993200 ↗
44. 10.1074/jbc.M50013020010.1074/jbc.M500130200 ↗
45. 10.1016/S0006-291X(02)02124-110.1016/S0006-291X(02)02124-1 ↗
46. 10.1359/jbmr.2002.17.2.26610.1359/jbmr.2002.17.2.266 ↗
47. 10.1053/joca.1998.023010.1053/joca.1998.0230 ↗
48. 10.1016/j.imlet.2004.08.01010.1016/j.imlet.2004.08.010 ↗
49. 10.1523/JNEUROSCI.23-33-10622.200310.1523/JNEUROSCI.23-33-10622.2003 ↗
50. 10.1002/jcp.104145020310.1002/jcp.1041450203 ↗
51. 10.1002/jbm.a.3013410.1002/jbm.a.30134 ↗